Skip to main content

Advertisement

Table 4 Duration of recombinant human follicle-stimulating hormone (r-hFSH) stimulation and total and daily r-hFSH doses required - primary efficacy analysis population (patients who received hCG injections)

From: Phase IV, open-label, randomized study of low-dose recombinant human follicle-stimulating hormone protocols for ovulation induction

  CLD group LD group Total p
(n = 94) (n = 91) (N = 185)
Duration of stimulation, days 13.7 +/− 6.33 12.9 +/− 5.58 13.3 +/− 5.97 0.36
Daily dose, IU 78.7 +/− 8.90 85.0 +/− 15.35 81.8 +/− 12.86 <0.001
Total dose, IU 1119.4 +/− 690.04 1155.5 +/− 730.45 1137.2 +/− 708.50 0.73
  1. Data are mean +/− standard deviation.
  2. p values show the difference between treatment groups using analysis of variance.
  3. Values in bold are significant.
  4. CLD = chronic low-dose; hCG = human chorionic gonadotrophin; LD = low-dose.